CN109549042A - A kind of Sparassis crispa liquid beverage - Google Patents
A kind of Sparassis crispa liquid beverage Download PDFInfo
- Publication number
- CN109549042A CN109549042A CN201811490433.4A CN201811490433A CN109549042A CN 109549042 A CN109549042 A CN 109549042A CN 201811490433 A CN201811490433 A CN 201811490433A CN 109549042 A CN109549042 A CN 109549042A
- Authority
- CN
- China
- Prior art keywords
- sparassis crispa
- weight
- liquid beverage
- parts
- extracting solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000272503 Sparassis radicata Species 0.000 title claims abstract description 51
- 239000007788 liquid Substances 0.000 title claims abstract description 37
- 235000013361 beverage Nutrition 0.000 title claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000003756 stirring Methods 0.000 claims abstract description 17
- 241001122767 Theaceae Species 0.000 claims abstract description 14
- 241000220317 Rosa Species 0.000 claims abstract description 13
- 241000628997 Flos Species 0.000 claims abstract description 11
- 241001646834 Mesona Species 0.000 claims abstract description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 6
- 235000003599 food sweetener Nutrition 0.000 claims description 6
- 239000001630 malic acid Substances 0.000 claims description 6
- 235000011090 malic acid Nutrition 0.000 claims description 6
- 239000003765 sweetening agent Substances 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 241001478240 Coccus Species 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
- 235000012976 tarts Nutrition 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 235000013616 tea Nutrition 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical group C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- -1 small molecule compound Chemical class 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001646828 Platostoma chinense Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000002305 glucosylceramides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- LGZXYFMMLRYXLK-UHFFFAOYSA-N mercury(2+);sulfide Chemical compound [S-2].[Hg+2] LGZXYFMMLRYXLK-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of Sparassis crispa liquid beverages, by weight: volume number=g/ml is calculated, and prepare as follows: the golden ear of the Sparassis crispa of 10-15 parts by weight and 2-4 parts by weight is added to the water stirring by S1., boils 20-30min, 1000 volume numbers are settled to, the first extracting solution is obtained；S2. the mesona of the FLOS CHRYSANTHEMI ALBA from Haizhou of China of 2-4 parts by weight, the rose tea of 1-3 parts by weight and 2-4 parts by weight is added to the water stirring, boils 20-30min, be settled to 1000 volume numbers, obtain the second extracting solution；S3. the first extracting solution and the second extracting solution are mixed, stirs evenly obtained Sparassis crispa liquid beverage.Sparassis crispa liquid beverage of the present invention has the effect of good blood pressure lowering.
Description
Technical field
The present invention relates to liquid beverage fields, and in particular to a kind of Sparassis crispa liquid beverage.
Background technique
Sparassis crispa (Sparassis Crispa) is a kind of dual-purpose of drug and food fungi of preciousness, enjoys the good reputation of " kings of ten thousand mushrooms ",
Effective component mainly has protein, polysaccharide, ergosterol, glucosylceramide, adenosine and some other small molecule compound
Deng；Contain a large amount of beta glucans, antioxidant, vitamin and mineral, superoxide dismutase and Wei Sheng in Sparassis crispa
The content of plain E occupies bacterium algae group food forefront, has a variety of pharmacology such as raising immunity, antitumor, anti-hypertension, anti-diabetic living
Property.Since the research starting of domestic Sparassis crispa is than later, in terms of being substantially parked in cultivation technique at present, for the combination of deep processing
The research of produce product is less, almost blank.
Summary of the invention
In view of this, in order to solve the above technical problems, being main former it is an object of the invention to propose a kind of with Sparassis crispa
The Sparassis crispa liquid beverage of material, has the effect of blood pressure lowering.
Used technical solution are as follows:
A kind of Sparassis crispa liquid beverage, by weight: volume number=g/ml is calculated, and is prepared as follows:
S1. the golden ear of the Sparassis crispa of 10-15 parts by weight and 2-4 parts by weight is added to the water stirring, boils 20-30min, it is fixed
Hold to 1000 volume numbers, obtains the first extracting solution；
S2. the mesona of the FLOS CHRYSANTHEMI ALBA from Haizhou of China of 2-4 parts by weight, the rose tea of 1-3 parts by weight and 2-4 parts by weight is added to the water and is stirred
It mixes, boils 20-30min, be settled to 1000 volume numbers, obtain the second extracting solution；
S3. the first extracting solution and the second extracting solution are mixed, stirs evenly obtained Sparassis crispa liquid beverage.
In the technical scheme,
Golden ear: because its color is golden yellow, also known as yellow fungus, because it is similar to human brain, also known as brain ear.Golden ear contains abundant fat,
The microelements such as protein and phosphorus, sulphur, manganese, iron, magnesium, calcium, potassium are a kind of tonic foods, and can be used as medicinal.The taste of golden ear
Value of building up one's health is a kind of ideal high grade spindle dinner delicacies and health-care good product better than the colloids mushroom such as tremella, black fungus.The golden ears or side handles of a utensil
Entity hemispherical, surface is orange to Chinese red when fresh, orange-yellow to golden yellow after doing；Dry after-contraction, it is hard, it is basic to keep former
Shape.Polysaccharides from Temelle aurantiabla mycelium is made of rhamnose, mannose, glucose, galactolipin, fucose；Fruitbody polysaccharide by glucose,
Glucuronic acid, mannose, xylose, rhamnose composition.
Medicinal function:
1. improving organism metabolism function, inhibit the growth of tumour cell.
2. adjusting organism metabolism function, improve body nutrition condition, improves the content of body hemoglobin and blood plasma.
3. improving body anti-aging, anti-anoxia ability, hypoglycemic, reducing blood lipid, norcholesterol.
4. promoting liver lipid metabolism, prevent fat from accumulating in liver, improves liver detoxification function.Often eating can be effectively
Illness prevention and fitness delays senescence.
FLOS CHRYSANTHEMI ALBA from Haizhou of China: FLOS CHRYSANTHEMI ALBA from Haizhou of China is one of Tongxiang traditional characteristics advantageous agricultural product, refers to and is grown in the territorial scope of Tongxiang, and presses
According to traditional handicraft or the product of steam beating, the production of pneumatic conveying drying new process.
Medical value:
1. Central nervous has sedation；
2. there is refrigeration function；
3. enhancing capillary resistance, coronary vasodilation；
It nourishes the liver to improve visual acuity, clear away heart-fire, kidney tonifying, strengthening the spleen and stomach, throat soothing, promoting the production of body fluid 4. having, and adjustment blood lipid and other effects.
Rose tea: rose tea is one kind of jasmine tea in China's reprocessing teas, is by tealeaves and fresh rose flower scenting
It forms.Rose tea energy fall fire gas enriching yin beauty, conditioning vim and vigour, promotes blood circulation, skin maintenance and cosmetic benefits, and has elimination fatigue, more
Wound is closed, liver gastrointestinal function is protected, long-term drinking also peomotes metabolism.
Mesona: also known as Mesona chinensis Benth, Chinese mesona herb, belong to annual herb perennial plant, property is sweet, light, cool.Clearing heat and promoting diuresis, cool blood.
It can be used for clear heat, quench one's thirst, remove heat toxin.
By after golden ear, FLOS CHRYSANTHEMI ALBA from Haizhou of China, rose tea and mesona reasonable compatibility, having on the whole good based on Sparassis crispa
The effect of good blood pressure lowering.
Preferably, in S3, the second extracting solution of the first extracting solution of 100 volume numbers and 100 volume numbers is mixed, and is added
The sweetener of 8-12 parts by weight and the acid of 0.1-0.2 parts by weight, stir evenly obtained Sparassis crispa liquid beverage.
The effect of sweetener and acid is to improve the mouthfeel of Sparassis crispa liquid beverage, increase appetite.
Further, the sweetener is one of sucrose, xylitol, stevioside or a variety of.
Further, the acid is one of citric acid, sodium citrate, malic acid or a variety of.
The present invention also correspondence provides a kind of preparation method of Sparassis crispa liquid beverage, is according to described in above scheme
What the step of Sparassis crispa liquid beverage, prepared.
Specifically, a kind of preparation method of Sparassis crispa liquid beverage, by weight: volume number=g/ml is calculated, including as follows
Step:
S1. the golden ear of the Sparassis crispa of 10-15 parts by weight and 2-4 parts by weight is added to the water stirring, boils 20-30min, it is fixed
Hold to 1000 volume numbers, obtains the first extracting solution；
S2. the mesona of the FLOS CHRYSANTHEMI ALBA from Haizhou of China of 2-4 parts by weight, the rose tea of 1-3 parts by weight and 2-4 parts by weight is added to the water and is stirred
It mixes, boils 20-30min, be settled to 1000 volume numbers, obtain the second extracting solution；
S3. the first extracting solution and the second extracting solution are mixed, stirs evenly obtained Sparassis crispa liquid beverage.
Preferably, in S3, the second extracting solution of the first extracting solution of 100 volume numbers and 100 volume numbers is mixed, and is added
The sweetener of 8-12 parts by weight and the acid of 0.1-0.2 parts by weight, stir evenly obtained Sparassis crispa liquid beverage.
To sum up, Sparassis crispa liquid beverage of the present invention has the effect of good blood pressure lowering on the whole.
Specific embodiment
Further details of elaboration is done to the present invention below.And zoopery is recorded in detail, to show that the present invention is had
Technical effect.
Embodiment 1
A kind of Sparassis crispa liquid beverage is prepared as follows:
S1. Sparassis crispa, 120 DEG C of golden ear are dried 10 minutes, then by 10g Sparassis crispa, 2g gold ear is added in 1000 milliliters of water,
It boils 20 minutes, is settled to 1000mL and obtains the first extracting solution；
S2. FLOS CHRYSANTHEMI ALBA from Haizhou of China 2g, rose tea 1g, mesona 2g are added to the water, and boil 20 minutes, are settled to after filtering with water
1000ML. obtains the second extracting solution；
S3. the second extracting solution of the first extracting solution of 100mL and 100mL are mixed, and sucrose 10g, citric acid is added
0.02g, sodium citrate 0.02g, malic acid 0.06g stir evenly obtained Sparassis crispa liquid beverage.
Embodiment 2
A kind of Sparassis crispa liquid beverage is prepared as follows:
S1. Sparassis crispa, 120 DEG C of golden ear are dried 10 minutes, then by 12g Sparassis crispa, 3g gold ear is added in 1000 milliliters of water,
It boils 20 minutes, is settled to 1000mL and obtains the first extracting solution；
S2. FLOS CHRYSANTHEMI ALBA from Haizhou of China 3g, rose tea 2g, mesona 3g are added to the water, and boil 20 minutes, are settled to after filtering with water
1000ML. obtains the second extracting solution；
S3. the second extracting solution of the first extracting solution of 100mL and 100mL are mixed, and sucrose 11g, citric acid is added
0.02g, sodium citrate 0.02g, malic acid 0.06g stir evenly obtained Sparassis crispa liquid beverage.
Embodiment 3
A kind of Sparassis crispa liquid beverage is prepared as follows:
S1. Sparassis crispa, 120 DEG C of golden ear are dried 10 minutes, then by 14g Sparassis crispa, 2g gold ear is added in 1000 milliliters of water,
It boils 20 minutes, is settled to 1000mL and obtains the first extracting solution；
S2. FLOS CHRYSANTHEMI ALBA from Haizhou of China 3g, rose tea 2g, mesona 3g are added to the water, and boil 20 minutes, are settled to after filtering with water
1000ML. obtains the second extracting solution；
S3. the second extracting solution of the first extracting solution of 100mL and 100mL are mixed, and xylitol 8g, stevioside is added
0.05g, citric acid 0.02g, sodium citrate 0.02g, malic acid 0.06g stir evenly obtained Sparassis crispa liquid beverage.
Embodiment 4
A kind of Sparassis crispa liquid beverage is prepared as follows:
S1. Sparassis crispa, 120 DEG C of golden ear are dried 10 minutes, then by 15g Sparassis crispa, 3g gold ear is added in 1000 milliliters of water,
It boils 20 minutes, is settled to 1000mL and obtains the first extracting solution；
S2. FLOS CHRYSANTHEMI ALBA from Haizhou of China 4g, rose tea 3g, mesona 4g are added to the water, and boil 20 minutes, are settled to after filtering with water
1000ML. obtains the second extracting solution；
S3. the second extracting solution of the first extracting solution of 100mL and 100mL are mixed, and xylitol 8g, stevioside is added
0.06g, citric acid 0.02g, sodium citrate 0.02g, malic acid 0.06g stir evenly obtained Sparassis crispa liquid beverage.
5 zoopery of embodiment
Experimental subjects: the susceptible type spontaneous hypertensive rat (Stroke-prone of the cerebral apoplexy of 100 six week old
Spontaneously Hypertensive rats, SHRsp).
100 rats are equally divided into control group and two groups of experimental group, it is 22-24 DEG C that two groups of rats, which are raised in temperature,
Humidity is the silk ball in the environment of 40-60%, in daily 9 points, the 13 points and 17 points minutes 3 feeding embodiments 1 of the rat of experimental group
Bacteria liquid beverage 10mL, other conditions are as control group.It measures the blood pressure of two groups of rats respectively every two weeks, and observes survival
Time.
The blood pressure conditions of 1 two groups of rats of table within 4 weeks
| 0 week | 2 weeks | 4 weeks | |
| Control group blood pressure/mmHg | 160 | 223 | 246 |
| Experimental group blood pressure/mmHg | 160 | 185 | 205 |
The rat of experimental group is obviously reduced after two weeks than the blood pressure of the rat of control group as can be seen from Table 1,
Sparassis crispa liquid beverage has good hypotensive activity.
The number of elements that 2 two groups of rats of table survive in 160 days
| 0 day | 20 days | 40 days | 60 days | 80 days | 100 days | 120 days | 140 days | 160 days | |
| Control group/only | 50 | 50 | 45 | 29 | 10 | 0 | 0 | 0 | 0 |
| Experimental group/only | 50 | 50 | 50 | 50 | 45 | 28 | 24 | 22 | 6 |
The rat of experimental group is obviously longer than the survival of rats time of control group as can be seen from Table 2, i.e., survival rate is high.
The series of detailed descriptions listed above are illustrated only for possible embodiments of the invention,
The protection scope that they are not intended to limit the invention, it is all without departing from equivalent embodiment made by technical spirit of the present invention or change
It should all be included in the protection scope of the present invention.
Claims (5)
1. a kind of Sparassis crispa liquid beverage, which is characterized in that by weight: volume number=g/ml is calculated, and is as follows
It prepares:
S1. the golden ear of the Sparassis crispa of 10-15 parts by weight and 2-4 parts by weight is added to the water stirring, boils 20-30min, is settled to
1000 volume numbers, obtain the first extracting solution；
S2. the mesona of the FLOS CHRYSANTHEMI ALBA from Haizhou of China of 2-4 parts by weight, the rose tea of 1-3 parts by weight and 2-4 parts by weight is added to the water stirring,
20-30min is boiled, 1000 volume numbers is settled to, obtains the second extracting solution；
S3. the first extracting solution and the second extracting solution are mixed, stirs evenly obtained Sparassis crispa liquid beverage.
2. Sparassis crispa liquid beverage according to claim 1, which is characterized in that in S3, the first of 100 volume numbers is extracted
The mixing of second extracting solution of liquid and 100 volume numbers, and the sweetener of 8-12 parts by weight and the tart flavour of 0.1-0.2 parts by weight is added
Agent stirs evenly obtained Sparassis crispa liquid beverage.
3. Sparassis crispa liquid beverage according to claim 2, which is characterized in that the sweetener is sucrose, xylitol, sweet tea
One of synanthrin is a variety of.
4. Sparassis crispa liquid beverage according to claim 2, which is characterized in that the acid is citric acid, citric acid
One of sodium, malic acid are a variety of.
5. a kind of preparation method of Sparassis crispa liquid beverage, which is characterized in that it is according to any embroidery of claim 1-4
What the step of coccus liquid beverage, prepared.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811490433.4A CN109549042A (en) | 2018-12-06 | 2018-12-06 | A kind of Sparassis crispa liquid beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811490433.4A CN109549042A (en) | 2018-12-06 | 2018-12-06 | A kind of Sparassis crispa liquid beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109549042A true CN109549042A (en) | 2019-04-02 |
Family
ID=65869358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811490433.4A Withdrawn CN109549042A (en) | 2018-12-06 | 2018-12-06 | A kind of Sparassis crispa liquid beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109549042A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111227143A (en) * | 2020-03-03 | 2020-06-05 | 福建万菇生物科技有限公司 | Sparassis crispa health-care beverage and preparation method thereof |
| CN115299536A (en) * | 2022-06-23 | 2022-11-08 | 福建容益菌业科技研发有限公司 | Sparassis crispa raw stock beverage and preparation method thereof |
-
2018
- 2018-12-06 CN CN201811490433.4A patent/CN109549042A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111227143A (en) * | 2020-03-03 | 2020-06-05 | 福建万菇生物科技有限公司 | Sparassis crispa health-care beverage and preparation method thereof |
| CN115299536A (en) * | 2022-06-23 | 2022-11-08 | 福建容益菌业科技研发有限公司 | Sparassis crispa raw stock beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105941700A (en) | Hippophae rhamnoide-Fu tea and preparation technology thereof | |
| CN106070779A (en) | A kind of Chinese caterpillar fungus hypha fermentation tea and processing method thereof | |
| CN109549042A (en) | A kind of Sparassis crispa liquid beverage | |
| CN105660957A (en) | Three-fruit herbal tea and making method thereof | |
| CN107668450A (en) | A kind of Rosa roxburghii fermented beverage and preparation method thereof | |
| KR101827873B1 (en) | Beverage composition with extract of Schisandra chinensis, Rubus coreanus, Lycium chinense, Torilis japonica, Cuscuta australis and concentrate of wild genseng fruit | |
| CN102366134B (en) | Kiwi fruit tremella sanguinea beverage and its preparation method | |
| CN107279983A (en) | The preparation method of paper mulberry tree cordyceps sinensis albumen peptide nutrient powder | |
| CN101845382A (en) | Plant SOD wine and preparation method thereof | |
| CN105961666A (en) | Tricholoma matsutake hypha fermented tea and processing method thereof | |
| CN105961670A (en) | Toadstool hypha fermented tea and processing method thereof | |
| CN109349483A (en) | A kind of plant energy functional beverage production method | |
| KR101329412B1 (en) | Method for producing Kimchi seasoning sauce using mushroom extract and Kimchi seasoning sauce prepared therefrom | |
| KR20100102890A (en) | Process of manufacture of ability drink that use medicinal plant extraction liquid | |
| KR20120056379A (en) | Method for producing Dangmyen with enhanced antioxidative activity adding purple sweet potato and Dangmyen produced by the same method | |
| CN109287991A (en) | A kind of blueberry puree and its preparation method and application | |
| CN107541415A (en) | A kind of root of kudzu vine alcoholic beverage and preparation method thereof | |
| CN105941687A (en) | Oyster mushroom hypha fermented tea and processing method thereof | |
| CN1056966C (en) | Seabuckthorn and chinese stone nutrient liquor | |
| CN106070780A (en) | A kind of mushroom mycelium fermented tea and processing method thereof | |
| CN104531444A (en) | Gingko fruit wine and preparation method thereof | |
| CN105901444B (en) | Health green plum drink and preparing method thereof | |
| KR102621081B1 (en) | Method for manufacturing seasoning sauce for shellfish and seafood | |
| CN104642576A (en) | Preparation method of concentrated health-care health-preserving tea product | |
| KR102636322B1 (en) | Method for manufacturing dried yellow corvina with gochujang and dried yellow corvina with gochujang produced thereby |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190402 |
|
| WW01 | Invention patent application withdrawn after publication |